Achieve Life Sciences, Inc. Royalty Expense
Achieve Life Sciences, Inc. (ACHV) reported Royalty Expense of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2013-03-07
- Achieve Life Sciences, Inc. royalty expense for the quarter ending 2012-12-31 was $0.00.
- Achieve Life Sciences, Inc. royalty expense for the quarter ending 2012-09-30 was $0.00.
- Achieve Life Sciences, Inc. royalty expense for fiscal 2012 was $0.00.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $0.00 derived: sum of 2 quarters · filed 2013-03-07 | $0.00 10-K · filed 2013-03-07 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |